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Background: Due to high optical absorption, triplet quantum yield and afﬁnity to biological structures
bichromophoric cyanine dyes (BCDs) can be considered promising sensitizers for application in photodynamic
therapy (PDT). In this work, we report on the study of the BCD photocytotoxicity toward melanoma and normal
cells in comparison with that of commercial photosensitizer Photogem®.
Methods: The cytotoxic andphototoxic effectsweremeasured by standard tests of cell viability. The drug uptakewas
obtained by the ﬂow cytometry and optical absorption techniques. The BCD intracellular distribution was obtained
by the ﬂuorescence image microscopy using speciﬁc organelle markers.
Results: Both drugs demonstrated increased cytotoxicity under irradiation, while in darkness their cytotoxic effect at
concentrations lower than 20 μM after 24 h of incubation did not exceed 20%. For 5 h of incubation, BCD
photocytotoxicity in relation to melanoma cells reached 100% already at concentrations below 5 μM, while for nor-
mal cells the effect did not exceed 70% even for the 20 μM concentration. It is shown that BCD penetrates into the
cells and is located predominantly in perinuclear cytoplasmic structures.
Conclusions: The BCD photosensitizing characteristics appear more adequate for application in PDT than that of the
actually applied commercial photosensitizer Photogem®. Higher light absorption by BCD in the near IR region and
its preferential localization in mitochondria can explain its high photocytotoxicity.
General signiﬁcance: BCD can be considered as a new promising photosensitizer class for cancer PDT.© 2014 Elsevier B.V. All rights reserved.1. Introduction
Cyanine dyes (CDs) are widely applied in biology as ﬂuorescence
probes due to their high optical absorption, intensive ﬂuorescence in
the visible region of the spectrum and high afﬁnity to cell structures [1,
2]. CD absorption spectrumcan easily be shifted to red and near infrared
spectral region by increasing π-conjugated chromophore chain length.
This stimulates the interest on the use of CD as photosensitizers (PS)
in photodynamic therapy of cancer (PDT) and as ﬂuorescence probes
in cancer ﬂuorescence diagnostics (PDD) [3–6]. Unfortunately, a signif-
icant increase of the π-conjugated chromophore chain length necessary
to shift the absorption to desirable spectrum region increases the ﬂexi-
bility of the chain, thus reducing theﬂuorescence and triplet state quan-
tum yields and reducing consequently the photochemical activity of the5 16 3602-4441; fax: +55 16molecule. Moreover, photoisomerization, characteristic for CD [7–10]
opens a channel for the excitation energy dissipation, reducing excited
state lifetimes and quantum yields even more and thus reducing the
CD efﬁcacy in both PDT and PDD.
The class of cyanine dyeswith two chromophores linked by a central
heterocycle (biscyanine dyes, BCDs) is free from these disadvantages
because the red shift of their absorption spectra is achieved due to di-
pole–dipole chromophore interaction and electron tunneling through
the central heterocycle [11,12] rather than due to the increase of chromo-
phore chain lengths. BCD possesses high molar absorption coefﬁcients
(ε N 105 M−1 cm−1 in the spectral range of 600–700 nm), high afﬁnity
to cell membranes and biomolecules [13] and high triplet quantumyields
[14,15]. This stimulates our interest to study BCD photocytotoxicity
towardmalignant cell cultures, taking into account their possible applica-
tion as PS in PDT.
In this work, we report on the study of the BCD photocytotoxicity
effect on B16F10 (mouse) and C8161 (human)melanoma cell lines, com-
pared to a normal cell line (PBMC) as a function of the dye concentration,
Fig. 1. (A) BCD and (B) Photogem® molecular structures.
1151L.S. Murakami et al. / Biochimica et Biophysica Acta 1850 (2015) 1150–1157incubation time and irradiation dose. The BCD photocytotoxicity was
compared to Photogem®, a Russian Photofrin® analogue PS used in
clinics for cancer treatment by PDT.
2. Materials and methods
2.1. Photosensitizers
Benzo[1,2-d:4,5-d′]bisthiazolium,2,6-bis[3-(1,3-dihydro-1-ethyl,3,3-
dimethyl- 2H-indol-2-ylidene)-1-propenyl]-3,7-diethyl (Fig. 1A), the
bichromophoric cyanine dye, is one of a series of BCD synthesized by Dr.
Felix Mikhailenko in the Institute of Organic Chemistry of the Academy
of Science of Ukraine. BCDwas puriﬁedbyDr.Mikhailenko, and the purity300 400 500 600 700 800
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Fig. 2. Normalized absorption and ﬂuorescence spectra of BCD and Photogem® in PBS.
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Fig. 3. Normalized absorption spectra of [BCD] = 3.5 μM in an aqueous solution; in the
presence of [NaCl] = 2 M and in the RPMI medium.degree was controlled by High Pressure Liquid Chromatography, optical
absorption and ﬂuorescence spectroscopy methods. The specialities
of BCD synthesis and puriﬁcation are presented in [16]. Photogem®
(Fig. 1B) was obtained from PHOTOGEM LLC (Moscow, Russia) and
used without additional puriﬁcation.
BCD and Photogem® stock solutions were prepared in ethanol and
water, respectively, concentrations being controlled by optical absorption
using the absorptionmolar coefﬁcients ε=1.33 × 105M−1 cm−1 at λ=
632 nm for BCD [13] and ε= 1.17 × 103 M−1 cm−1 at λ= 630 nm for
Photogem® [17].
Sodium dodecyl sulfate (SDS) was used to measure the BCD absorp-
tion spectra at its interaction with micelles as the simpliﬁed membrane
model. SDS concentration used was 20 mM, which is twice higher thanA)
B)
μ
μ
Fig. 4. Cellular uptake of BCD in B16F10 cells. (A) Concentration dependence on the BCD
internalization after 6 h of incubation obtained by ﬂow cytometry. Inset: Dependence of
integral ﬂuorescence intensity in positive cells on BCD concentration. (B) Comparison
between BCD uptake determined by (○) ﬂow cytometry, [BCD] = 2 μM and (■) optical
absorption, as a function of time.
1152 L.S. Murakami et al. / Biochimica et Biophysica Acta 1850 (2015) 1150–1157its critical micelle concentration (c.m.c). SDS was obtained from Sigma
Co. and used without additional puriﬁcation.2.2. Cell culture conditions
B16F10 murine melanoma and human melanoma (C8161) cell
lines were originally obtained from American Type Culture Collec-
tion (Rockville, MD). Peripheral blood mononuclear cells (PBMC)
were extracted from healthy human volunteers by centrifugation
in density gradient using the Ficoll–Hypaque technique (Sigma Diagnos-
tics, Inc., Missouri, USA).
All cell lines were allowed to grow to conﬂuence in RPMI 1640
medium with phenol red and supplemented with 10% FCS, glutamine
and antibiotics, at 37 °C in 5%CO2, 95% air, and a humidiﬁed atmosphere.
All reagents were obtained from Gibco-Invitrogen, Carlsbad, CA.
The adherent cells were washed 3 times with PBS and subcultured
by dispersal with trypsin–EDTA (2.5 g/L) (Sigma-Aldrich, St. Louis, Mo,
USA), centrifuged at 1000 rpm for 15 min at 10 °C in complete medium
and seeded. Cells were placed in 96-well plates with 0.2 mL of culture
medium per well at a density of 5 × 104 cells per well. After 24 h of cul-
ture, themediumwas removed and fresh RPMIwith different concentra-
tions of BCD formulations (1–20 μM) was added to the wells (stock
solutions of sensitizers (5 mg/mL) were prepared in ethanol (BCD) and
PBS (Photogem®) and dilutions were performed in RPMI.
Cells were incubated and then the sensitizer solutions were removed
before a fresh complete medium was added. Since the absorption spec-
trum of phenol red typically presented in RPMI 1640 medium coincides
with BCD spectrum, in these experiments, we used culture medium free
of phenol red.Fig. 5. BCD cell uptake and intracellular localization in B16F10 cells obtainedwith a LeicaMicros
and incubated during (A) 5 min, (B) 15 min, (C) 30 min and (D) 120 min.2.3. Cellular uptake
a) Flow cytometry: the cellular uptake of BCD in B16F10 cells was per-
formed using a ﬂuorescence-activated cell scanner (BD FACSCanto,
Becton Dickinson) equipped with an argon ion laser providing
excitation at 488 nm. Cells were incubated with BCD in the dark
from 15 min to 18 h and then washed and resuspended in PBS.
Cell suspensions were excited and ﬂuorescence signal of drug up-
take was detected using a 670 nm long-pass ﬁlter. The analysis
was performed using FACSDiva software. Each analyzed sample
contained a minimum of 104 cells.
b) Optical absorption: 1 × 106 cells were seeded onto 50 cm3 ﬂask and
allowed to grow for 24 h prior to treatment with BCD at the con-
centration of 50 μMin complete culturemedium. Cellswere incubat-
ed with BCD in the dark from 30 min to 18 h and then washed 5
times with PBS and resuspended in 5 mL of NaOH 0.1 M solution
containing SDS 1%. After each interval of incubation, the absorbance
of the sample was recorded and the resulting concentration was ob-
tained with a calibration curve of the PS in a cell lysate SDS solution
(procedure modiﬁed from [18]).
2.4. Cellular uptake and intracellular localization by ﬂuorescence imaging
microscopy
Experimentswere carried outwith a LeicaMicrosystemDM6000Bmi-
croscope. Speciﬁc organelles staining probes were used. Mitochondria
were stained with bothMitotracker Green™ (Molecular Probe) and Rho-
damine 123 (Sigma Chemical Co.). 4′,6-Diamino-2-phenylindole (DAPI)ystemDM6000B FluorescenceMicroscopewith anN2.1 ﬁlter. Cells were treatedwith BCD
Fig. 6.B16F10 cells after incubationwith: (A), (D) and (G) BCD (120min); (B) Rhodamine 123 (30min); (C) superposition of A and B; (E)Mitotracker Green™ (30min); (F) superposition
of D and E; (H) DAPI (30 min) and (I) superposition of G and H.
1153L.S. Murakami et al. / Biochimica et Biophysica Acta 1850 (2015) 1150–1157(Molecular Probe) was used as a nuclei probe. A ﬁlter set N2.1 (BP 515–
560 nm, FT 580 nm, LP 590 nm) was used for BCD; L5 (BP 480 nm, FT
505 nm, LP 527 nm) forMitotracker Green™ and Rhodamine 123, andﬁl-
ter set A for DAPI (BP 340–380 nm, FT 400 nm, LP 425 nm). In all ﬂuores-
cence imaging experiments, cells were grown in 96-well culture plates
and were washed after incubation and prior to measurements.Fig. 7.Dark cytotoxic effect (CTE) of BCD (A) and Photogem® (B) after 24 h of incubation as a fu
cells and PBMC-human peripheral blood mononuclear cells.2.5. Photocytotoxicity assay
Irradiations were performed using the standard light source with
a halogen lamp (250W) equipped with a color 3-69 KOPP glass ﬁlter
with the light transmittance range λ N 500 nm (Fig. S1 in Supplementary
data).nction of drug concentration in B16F10-murinemelanoma cells; C8161-humanmelanoma
1154 L.S. Murakami et al. / Biochimica et Biophysica Acta 1850 (2015) 1150–1157Irradiation intensity at the plate positionwas 11mW/cm2measured
by a Spectra-Physics 407A radiometer and irradiation times were ad-
justed in order to obtain 10, 20, 30, 40, 50, 60 and 70 J/cm2 ﬂuences.
In all experiments controls were as follows: wells containing cells treat-
ed with photosensitizer but not exposed to light, wells containing cells
without photosensitizer and without light, and wells containing cells
without photosensitizer and exposed to light. The cells with and with-
out PS (control) were irradiated directly in the culture plates, under
sterile conditions. After irradiation, all cells were incubated for 24 h at
37 °C in 5% CO2, 95% air and a humidiﬁed atmosphere.
Cell viabilitywasmeasured bydetermination ofmitochondrial activ-
ity using the 3-(4,5-dimethylthiazol-2-yl) diphenyltetrazolium bro-
mide (MTT) assay, according to the method described by Mosmann
[19]. As such, the culture medium was replaced and 100 μL of MTT
(0.5 mg/mL) was added to eachwell, and then the cells were incubated
for a further 3 h at 37 °C. Subsequently, the formed formazan crystals
were dissolved in DMSO (200 μL/well) for 2 h. The absorbance of each
well was measured at 570 nm using a μQuant ELISA microplate reader
(BioTek Instruments, Winooski, VT). The cytotoxic effect (CTE) was cal-
culated as follows:
CTE %ð Þ ¼ 1− absorbance treated cells
absorbance untreated cells
 
 100:
BCD and Photogem® 50% lethal concentrations (LC50) were deter-
mined from CTE dependence on PS concentration at a ﬁxed irradiation
dose of 40 J/cm2 for B16-F10, C8161 and PBMC cell lines.
3. Statistical analysis
The results are given as an arithmetic mean value ± standard devi-
ation (X ± S.D.) of 6 independent experiments. Statistical comparisons
were made using Student's t-test with P b 0.05 as the minimal level of
signiﬁcance using Prism 4.0 Version Software.
3.1. Optical absorption measurements
Absorbance of the samples atλ=570 nm, aswell as BCD absorption
spectra in the spectral range of 500–700 nm in the RPMI1640 medium
with and without cell cultures before the irradiation, were monitored
by a μ-Quant BioTek Instruments spectrophotometer directly in the cul-
ture plates. BCD absorption spectra in the range of 500–700 nm were
alsomonitored in aqueous and SDSmicelle solutions in 1 cm quartz cu-
vette using a Beckmann Coulter DU640 spectrophotometer.0
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Fig. 8. Dependence of the photocytotoxicity of BCD and Photogem® on the irradiat4. Results and discussion
4.1. BCD spectral characteristics
To give a brief introduction on the spectral characteristics of
biscyanine (BCD) in comparison to that of the Photogem®, the absorption
and emission spectra of both photosensitizers are presented in Fig. 2. As a
porphyrin derivative, Photogem® is characterized by a high molar ab-
sorption coefﬁcient in the Soret region (105 M−1 cm−1) and relatively
weak absorption in the Q region (ε630 nm = 1.17 × 103 M−1 cm−1)
[17]. On the other hand, in dilute solutions (b10−6 M) BCD has high
light absorption in the region between 500 and 700 nm (ε632 nm =
1.33 × 105 M−1 cm−1) [13]. The BCD ﬂuorescence emission spectrum
shows the maximum at 644 nm, with a shoulder around 706 nm.
These characteristics are associated with BCD in monomeric form.
The Photogem® ﬂuorescence maximum is localized at 626 nm. The ﬂuo-
rescence quantum yields in PBS are 0.16 and 0.018 for Photogem® and
BCD, respectively.
Fig. 3 shows the changes in the absorption spectra of BCD in different
situations. In the RPMImedium a new absorption band in BCD spectrum
with the maximum localized at λ ≈ 690 nm appears. The same band
was also observed in BCD solution in the presence of NaCl. The relative
intensity of this band increaseswhen BCD and/or salt concentrations in-
crease. This absorption band was associated with the formation of BCD
J-aggregates [13]. This fact can be essential for BCD application, since
in general the aggregation reduces lifetimes and quantumyields of pho-
tosensitizer excited states [13,20–22], thus reducing its efﬁcacy in PDT.
However, at the BCD interaction with nanoorganized structures,
such as SDS micelles (Fig. S2, Supplementary data) or DNA [13], the ab-
sorption band at 690 nm disappears, indicating BCD disaggregation.
Based on this fact we may expect that the BCD interaction with cell
culture will induce its disaggregation. Really, the monitoring of absorp-
tion spectrum of BCD incubated with B16F10 cells as a function of time
showed that for incubation times between 30 min and 24 h BCD in rel-
atively high concentration (50 μM) remains in its monomeric form
(Fig. S2, Supplementary data).
4.2. Cell internalization
Cellular uptake of BCD was determined on the basis of the cellular
ﬂuorescence intensity using ﬂow cytometry and ﬂuorescence image
microscopy.
Fig. 4 shows the concentration and time dependences of BCD inter-
nalization obtained by ﬂow cytometry. After 6 h of incubation in the
cells, the BCD saturation concentration was found to be around 2 μM
(Fig. 4A). The sensitizer uptake increased during the ﬁrst 3 h reaching0 10 20 30 40 50 60 70 80
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1155L.S. Murakami et al. / Biochimica et Biophysica Acta 1850 (2015) 1150–1157the saturation for incubation times longer than 4 h (Fig. 4B).We should
note that similar levels ofﬂuorescence intensitywere found after 18h of
incubation with 2 μM of BCD, conﬁrming the negligible drug release
during this time interval (Fig. 4B). The high BCD ﬂuorescence intensityFig. 9. Photocytotoxic effect (CTE) of (1) BCD and (2) Photogem® against: A) B16F10—murine
mononuclear cells at different concentrations and incubation times at and irradiation dose of 4(Fig. 4A, inset) shows that inside the cells this compound is found in
the monomeric form.
Similar results were obtained by ﬂuorescence microscopy. Cells
were incubated with 5 μM of BCD and the images of the sensitizermelanoma cells; B) C8161—human melanoma cells; C) PBMC—human peripheral blood
0 J/cm2.
Table 1
BCD and Photogem® LC50 under illumination (irradiation dose of 40 J/cm2).
Cell line Incubation time (h) BCD LC50 (μM) Photogem® LC50 (μM)
B16F10 5.0 b1 1.46
C8161 2.0 1.61 3.80
PBMC 0.5 1.80 5.63
1156 L.S. Murakami et al. / Biochimica et Biophysica Acta 1850 (2015) 1150–1157ﬂuorescence emission in cellular medium as a function of incuba-
tion time were viewed with the help of a ﬂuorescence microscope
using an appropriate ﬁlter set. Fig. 5 shows the time-course of BCD
internalization.
After 5 min of incubation with BCD, multiple ﬂuorescent points at
the membrane surface were observed, suggesting the binding of BCD
with the cell membrane (Fig. 5A). With 15 min of incubation, BCD ﬂuo-
rescence at themembrane surface becomes more intense (Fig. 5B). This
increase of the BCD ﬂuorescence intensity may be associated with BCD
monomer binding with cell structures. It conﬁrms the optical absorp-
tion data shown earlier, indicating that BCD is in its monomeric form
in the presence of cells, since BCD aggregates have no ﬂuorescence. For-
merly [13] it was demonstrated that the ﬂuorescence quantum yield of
BCDmonomers, being just 0.02 in homogeneous aqueous solutions, in-
creases up to 0.45 at its binding with micelles or with DNA. The ob-
served images demonstrated that the association of BCD with cell
structures also increases its ﬂuorescence intensity conﬁrming that it is
in the monomeric form.
After 30min of incubation, BCD ﬂuorescence was diffusively distrib-
uted throughout the cytoplasm and detected inside endosome vesicles
in the cell cytosolic compartments (Fig. 5C). Finally, after 120 min we
observed that an intensive BCD ﬂuorescence was still at perinuclear cy-
toplasm structures (Fig. 5D).
To evaluate more precisely the site of intracellular localization of
BCD, comparative analysis of sensitizer ﬂuorescence emission pattern
to those characteristics of standard probes was performed (Fig. 6).
The similarity between the ﬂuorescence pattern of BCD and mito-
chondria probes (Fig. 6A–F) shows that BCD localizes preferentially
in a region near to the mitochondria. This was not observed with the
nuclei probe DAPI (Fig. 6G–I), suggesting an unlikely nuclear BCD
localization.
Mitochondria have been found to be a very important subcellular
target for many PS used in PDT, including the ﬁrst generation ones,
such as Photogem® and its analogue Photofrin®. The mitochondrial
damage after these PS illuminations leads to cell death by apoptosis
[23] emphasizing the importance of subcellular location/target of the
PS in PDT.
4.3. Photocytotoxicity
After 24 h of incubation, BCD and Photogem® cytotoxic effect (CTE)
in darkness for drug concentrations varying from 1 to 20 μM did not
exceed 20% (Fig. 7). CTE values were calculated as described in
Section 2.5. Cells incubated without drug were used as the control.
In the view to choose the adequate irradiation dose for the
photocytotoxicity tests, B16F10 cells were incubated for 2 h with BCD
and Photogem® and then exposed to ﬂuences from 10 to 70 J/cm2
(Fig. 8).
It was observed that BCD had a signiﬁcant CTE due to light exposure
at all ﬂuences, while for Photogem® the CTEwas expressive only when
the irradiation doses were ≥40 J/cm2. Besides, BCD presented a higher
CTE when compared to Photogem® in all concentrations used. Similar
results were obtained using C8161 cells (data not shown). Since the
saturation at 40 J/cm2 was observed for both compounds, this dose
was chosen to perform the photocytotoxic assays with all cell lines.
CTE of both BCD and Photogem® in relation to B16F10, C8161 and
PBMC as a function of the incubation time and drug concentration at
40 J/cm2 irradiation dose are shown in Fig. 9A–C.
When illuminated, both drugs demonstrated cytotoxicity much
higher than in darkness, the effect depending on the incubation time.
BCD photocytotoxicity reached saturation after 4 h of incubation
for B16F10 cells and after 2 h for C8161 cells,whereas Photogem®need-
ed just 1 h of incubation for both cell lines (Fig. 9A and B). The
photocytotoxicity of both BCD and Photogem® in relation to B16F10
cells reached the maximum at concentrations approaching 5 μM,
whereas in relation to C8161 cells concentrations were 5 μM for BCDand 20 μM for Photogem®. For PBMC cells, the incubation time neces-
sary to achieve the maximum photocytotoxicity was 0.5 h for both
drugs (Fig. 9C).
The LC50 values (Table 1) were determined from CTE dependence on
BCD concentration at a ﬁxed irradiation dose of 40 J/cm2, according to
the data from Fig. 9, and the incubation times of 5 h for B16F10, 2 h
for C8161 and 0.5 h for PBMC cells were chosen, respectively. For
B16F10 and C8161 cells, Photogem® LC50 was, approximately, twice
higher than BCD LC50.
These results are in good agreementwith those obtained by ﬂow cy-
tometry experiments, since the maximum uptake for BCD in B16F10
cells was obtained after 4 h of incubation and at the concentration of
1 μM it was higher than 97%.
We have also observed that under illumination BCD LC50 for PBMC
cells was 3 times lower than for Photogem®. On the other hand, maxi-
mal BCD photocytotoxic effect for PBMC cells did not exceed 70%,
whereas for Photogem® it reached 80%. Thus, it may be concluded
that in similar conditions Photogem® photocytotoxicity against PBMC
cells is higher, as compared with BCD.
So, this study demonstrated that BCD photocytotoxicity for melano-
ma cells is similar or higher than Photogem® one, whereas for normal
cells it is lower than the latter. The incubation time necessary for BCD
photocytotoxicity reachingmaximumwas about 4 h. Then at concentra-
tions b5 μM it demonstrated 100% CTE in relation to melanoma cells. At
the same time, its cytotoxicity in darkness toward all used cell lines did
not exceed 20%. The mitochondrial localization of BCD can explain its
high photocytotoxicity since the main mechanisms of cellular death,
both necrosis and apoptosis, are associated with mitochondria [23].
Based on these results, we conclude that BCD can be considered as a
promising compound for photodynamic therapy of cancer.Acknowledgements
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